SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001387131-16-007045
Filing Date
2016-09-23
Accepted
2016-09-22 17:50:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDED REGISTRATION STATEMENT admp-s3a_091916.htm S-3/A 247394
2 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN ex5-1.htm EX-5.1 12230
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-2.htm EX-23.2 3629
4 CONSENT OF HUDSON, CISNE ? CO. LLP ex23-3.htm EX-23.3 3402
  Complete submission text file 0001387131-16-007045.txt   267754
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-212880 | Film No.: 161898339
SIC: 2834 Pharmaceutical Preparations